Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000619309 | SCV000736766 | uncertain significance | Cardiovascular phenotype | 2017-02-17 | criteria provided, single submitter | clinical testing | The p.E15111Q variant (also known as c.45331G>C), located in coding exon 153 of the TTN gene, results from a G to C substitution at nucleotide position 45331. The glutamic acid at codon 15111 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |